The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(2-hydroxyethyl)-5-methyl-1-oxa-5-azaspiro[5.5]undeca-7,10-diene-4,9-dione ID: ALA5204697
Chembl Id: CHEMBL5204697
PubChem CID: 164883894
Max Phase: Preclinical
Molecular Formula: C12H15NO4
Molecular Weight: 237.25
Associated Items:
Names and Identifiers Canonical SMILES: CN1C(=O)C(CCO)COC12C=CC(=O)C=C2
Standard InChI: InChI=1S/C12H15NO4/c1-13-11(16)9(4-7-14)8-17-12(13)5-2-10(15)3-6-12/h2-3,5-6,9,14H,4,7-8H2,1H3
Standard InChI Key: GWWSDNTYMAZZOF-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 237.25Molecular Weight (Monoisotopic): 237.1001AlogP: -0.14#Rotatable Bonds: 2Polar Surface Area: 66.84Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 0.29CX LogD: 0.29Aromatic Rings: ┄Heavy Atoms: 17QED Weighted: 0.73Np Likeness Score: 1.14
References 1. Dhorma LP, Teli MK, Nangunuri BG, Venkanna A, Ragam R, Maturi A, Mirzaei A, Vo DK, Maeng HJ, Kim MH.. (2022) Positioning of an unprecedented 1,5-oxaza spiroquinone scaffold into SMYD2 inhibitors in epigenetic space., 227 [PMID:34656041 ] [10.1016/j.ejmech.2021.113880 ]